Home — News & Events
News & EventsTheertha on the world stage.
From the partnering floors of the world's largest biotech gatherings to the tables where the next collaborations begin — here is where Theertha Biopharma has been, and where you'll find us next.
PepXen™ goes global at BIO 2026
At the BIO International Convention in San Diego, Theertha introduced PepXen™ — a high-expression platform that delivers more product in less volume, with better economics — to the global peptide and insulin community.
Read more
Theertha Biopharma at the BIO International Convention
From booth 3351‑S in San Diego, our team held partnering meetings with biotech, pharma and investment leaders from the US, Europe and beyond — introducing Theertha's integrated development model.
Read moreTheertha to attend the Pharma Partnering Summit
Carrying our BIO momentum forward, Theertha will join the Pharma Partnering Summit in the United States this November. If you are advancing a biologics, biosimilar or cell & gene therapy programme, let's meet.
Read more
New paper: microbial systems for next-generation CAR therapies
A peer-reviewed paper co-authored by Theertha Biopharma in Current Microbiology explores a synthetic-biology paradigm for enhancing CAR-based cancer immunotherapy.
Read more
Research: extracellular vesicles for heart-tissue regeneration
Published in BioFactors, Theertha-affiliated research reviews extracellular vesicles (exosomes) as a promising therapeutic tool for regenerating heart tissue — underpinning our exosome platform.
Read more
Research: Galectin-3 and oral mesenchymal stem cells
Published in Biomedicines, Theertha R&D research examines how Galectin-3 modulates the LPS-induced inflammatory response of oral mesenchymal stem cells.
Read more
Bring us your molecule.
Whether we met at BIO or you are finding us here first — tell us what you are building, and we will tell you honestly how we can help.